Evidence map›Paper›PMID 7520466›Full record

ArticleThe Journal of experimental medicine1994

The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras.

J A Nunès, Y Collette, A Truneh, D Olive, D A Cantrell

Open access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 160 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Deficiency of small GTPase Rac2 affects T cell activation.The Journal of experimental medicine · 2001
    Article
  9. Single-cell analysis of signal transduction in CD4 T cells stimulated by antigen in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article
  10. Article
  11. Regulatory and signaling properties of the Vav family.Molecular and cellular biology · 2000
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. CD28: a signalling perspective.The Biochemical journal · 1996
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

J A NunèsLymphocyte Activation Laboratory, Imperial Cancer Research Fund, London, United Kingdom.
Y Collette
A Truneh
D Olive
D A Cantrell
The Honourable Society of Lincoln's Inn · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD28 is a 44-kD homodimer expressed on the surface of the majority of human T cells that provides an important costimulus for T cell activation. The biochemical basis of the CD28 accessory signals is poorly understood. Triggering of the T cell antigen receptor (TCR) activates the p21ras proteins. Here we show that ligation of CD28 by a monoclonal antibody (mAb) also stimulates p21ras and induces Ras-dependent events such as stimulation of the microtubule-associated protein (MAP) kinase ERK2 and hyperphosphorylation of Raf-1. One physiological ligand for CD28 is the molecule B7-1. In contrast to the effect of CD28 mAb, the present studies show that interactions between CD28 and B7-1 do not stimulate p21ras signaling pathways. Two substrates for TCR-regulated protein tyrosine kinases (PTKs) have been implicated in p21ras activation in T cells: p95vav and a 36-kD protein that associates with a complex of Grb2 and the Ras exchange protein Sos. Triggering CD28 with both antibodies and B7-1 activates cellular PTKs, and we have exploited the differences between antibodies and B7-1 for p21ras activation in an attempt to identify critical PTK-controlled events for Ras activation in T cells. The data show that antibodies against TCR or CD28 induce tyrosine phosphorylation of both Vav and p36. B7-1 also induces Vav tyrosine phosphorylation but has no apparent effect on tyrosine phosphorylation of the Grb2-associated p36 protein. The intensity of the Vav tyrosine phosphorylation is greater in B7-1 than in TCR-stimulated cells. Moreover the kinetics of Vav tyrosine phosphorylation is prolonged in the B7-1-stimulated cells. These studies show that for CD28 signaling, the activation of p21ras correlates more closely with p36 tyrosine phosphorylation than with Vav tyrosine phosphorylation. However, the experiments demonstrate that Vav is a major substrate for B7-activated PTKs and hence could be important in CD28 signal transduction pathway.

Indexed as

Adaptor Proteins, Signal TransducingCell Cycle ProteinsSignal TransductionAntibodies, MonoclonalB7-1 AntigenCalcium-Calmodulin-Dependent Protein KinasesCD28 AntigensGRB2 Adaptor ProteinHumansMembrane ProteinsPhosphorylationProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-vavProto-Oncogene Proteins p21(ras)Son of Sevenless ProteinsAdaptor Proteins, Signal TransducingAntibodies, MonoclonalB7-1 AntigenCalcium-Calmodulin-Dependent Protein KinasesCD28 AntigensCell Cycle ProteinsGRB2 Adaptor ProteinGRB2 protein, humanHRAS protein, humanMembrane ProteinsProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-vavProto-Oncogene Proteins p21(ras)Son of Sevenless ProteinsTyrosineVAV1 protein, human

Identifiers

PMID7520466
PMCPMC2191634
OpenAlexW2083984611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.